La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
DexCom Gestione
Gestione criteri di controllo 4/4
DexCom's Il CEO è Kevin Sayer, nominato in Jun2011, e ha un mandato di 13.17 anni. la retribuzione annua totale è $ 15.71M, composta da 7% di stipendio e 93% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.043% delle azioni della società, per un valore di $ 13.01M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.6 anni e 8.6 anni.
Informazioni chiave
Kevin Sayer
Amministratore delegato
US$15.7m
Compenso totale
| Percentuale dello stipendio del CEO | 7.0% |
| Mandato del CEO | 13.3yrs |
| Proprietà del CEO | 0.04% |
| Durata media del management | 2.7yrs |
| Durata media del Consiglio di amministrazione | 8.7yrs |
Aggiornamenti recenti sulla gestione
Recent updates
DexCom: Investors Discounting Long CGM Growth Runway
Sep 19We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)
Sep 16
DexCom Q2 Earnings: Traditional Market Overreaction
Aug 07Is Now The Time To Look At Buying DexCom, Inc. (NASDAQ:DXCM)?
Jul 26DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures
Jul 26Why Investors Shouldn't Be Surprised By DexCom, Inc.'s (NASDAQ:DXCM) P/E
Jul 12DexCom's ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact
Jul 03DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Jun 28Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Jun 03Dexcom: Positive Catalysts Ahead To Support Growth
May 13If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity
May 07DexCom: Attractive Discount After Strong Earnings Results
May 06Returns At DexCom (NASDAQ:DXCM) Are On The Way Up
Apr 25Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price
Apr 12DexCom Is Pricey For A Reason - Its Growth Story Reflects That
Apr 11Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Mar 04DexCom: A Wealth Compounder In Healthcare
Feb 14DexCom: Stelo Stellar Outlook
Jan 17DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Jan 15DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing
Jan 01DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Dec 05At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?
Nov 21DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital
Sep 28DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Aug 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Aug 14DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital
May 16Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?
Mar 21These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price
Feb 13DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly
Nov 25Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$667m |
| Mar 31 2024 | n/a | n/a | US$639m |
| Dec 31 2023 | US$16m | US$1m | US$542m |
| Sep 30 2023 | n/a | n/a | US$377m |
| Jun 30 2023 | n/a | n/a | US$358m |
| Mar 31 2023 | n/a | n/a | US$293m |
| Dec 31 2022 | US$15m | US$953k | US$341m |
| Sep 30 2022 | n/a | n/a | US$244m |
| Jun 30 2022 | n/a | n/a | US$230m |
| Mar 31 2022 | n/a | n/a | US$258m |
| Dec 31 2021 | US$12m | US$900k | US$217m |
| Sep 30 2021 | n/a | n/a | US$577m |
| Jun 30 2021 | n/a | n/a | US$562m |
| Mar 31 2021 | n/a | n/a | US$530m |
| Dec 31 2020 | US$14m | US$800k | US$550m |
| Sep 30 2020 | n/a | n/a | US$231m |
| Jun 30 2020 | n/a | n/a | US$205m |
| Mar 31 2020 | n/a | n/a | US$148m |
| Dec 31 2019 | US$10m | US$691k | US$101m |
| Sep 30 2019 | n/a | n/a | -US$171m |
| Jun 30 2019 | n/a | n/a | -US$170m |
| Mar 31 2019 | n/a | n/a | -US$130m |
| Dec 31 2018 | US$10m | US$601k | -US$127m |
| Sep 30 2018 | n/a | n/a | US$43m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$33m |
| Dec 31 2017 | US$8m | US$546k | -US$50m |
Compensazione vs Mercato: La retribuzione totale di Kevin ($USD 15.71M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 13.21M ).
Compensazione vs guadagni: La retribuzione di Kevin è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Kevin Sayer (66 yo)
13.3yrs
Mandato
US$15,712,244
Compensazione
Mr. Kevin Ronald Sayer has been Executive Chairman of DexCom, Inc. since July 30, 2018. Mr. Sayer has been the Chief Executive Officer of DexCom, Inc. since January 5, 2015 and as its President since June...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 13.3yrs | US$15.71m | 0.043% $ 11.7m | |
| Executive VP | 4.5yrs | US$4.25m | 0.0088% $ 2.4m | |
| Executive VP & COO | 2.1yrs | US$4.94m | 0.065% $ 17.4m | |
| Executive VP & Chief Legal Officer | 2.7yrs | US$4.34m | 0.0013% $ 358.6k | |
| Executive VP & Chief Commercial Officer | 1.7yrs | US$6.53m | 0.0016% $ 442.2k | |
| Executive VP & CTO | 1.9yrs | US$4.05m | 0.0013% $ 361.3k | |
| Senior VP & Chief Information Officer | less than a year | Nessun dato | Nessun dato | |
| Director of Corporate Affairs & Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| Executive Vice President of Strategy | 3.5yrs | Nessun dato | 0% $ 0 | |
| Executive Vice President of Marketing | less than a year | Nessun dato | Nessun dato | |
| Executive VP & Chief Human Resources Officer | 4yrs | Nessun dato | 0.0058% $ 1.6m | |
| Executive VP & MD of Dexcom Ventures | 3.4yrs | US$3.02m | 0.021% $ 5.8m |
2.7yrs
Durata media
49yo
Età media
Gestione esperta: Il team dirigenziale di DXCM è considerato esperto (durata media dell'incarico 2.6 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive Chairman | 16.8yrs | US$15.71m | 0.043% $ 11.7m | |
| Lead Independent Director | 9.8yrs | US$393.51k | 0.014% $ 3.8m | |
| Independent Director | 10.8yrs | US$343.40k | 0.014% $ 3.8m | |
| Independent Director | 15.2yrs | US$346.49k | 0.094% $ 25.4m | |
| Independent Director | 14.8yrs | US$362.21k | 0.0092% $ 2.5m | |
| Independent Director | 5yrs | US$346.49k | 0.0054% $ 1.5m | |
| Independent Director | 3.9yrs | US$343.40k | 0.0039% $ 1.0m | |
| Independent Director | 4.1yrs | US$345.90k | 0.0038% $ 1.0m | |
| Independent Director | 7.5yrs | US$345.90k | 0.0098% $ 2.6m | |
| Independent Director | 1.1yrs | US$404.72k | 0% $ 0 |
8.7yrs
Durata media
63yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di DXCM sono considerati esperti (durata media dell'incarico 8.6 anni).